Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Qingfei Granule is a traditional Chinese medicine (TCM) herbal formulation in granule form, used primarily for the treatment of acute upper respiratory tract infections, especially in pediatric populations. It is designed to relieve symptoms such as fever, sore throat, cough, and nasal congestion associated with wind-heat syndrome according to TCM principles. The formulation consists of multiple herbal ingredients (specific composition not detailed in the available sources), and it is intended as an alternative or adjunct to antibiotics for bacterial upper respiratory tract infections due to concerns about antibiotic resistance. Clinical studies are ongoing to assess its antibacterial effects and symptom relief efficacy in children with acute upper respiratory tract infection[6][7]. The mechanism of action is presumed multi-targeted based on TCM theory—likely involving anti-inflammatory and immunomodulatory effects—but specific molecular targets are not defined.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Qingfei Granule.